109 related articles for article (PubMed ID: 16936421)
21. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
22. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.
Glorioso N; Troffa C; Filigheddu F; Dettori F; Soro A; Parpaglia PP; Collatina S; Pahor M
Hypertension; 1999 Dec; 34(6):1281-6. PubMed ID: 10601131
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
Steinhagen-Thiessen E
Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
[TBL] [Abstract][Full Text] [Related]
24. Maintenance of low-density lipoprotein goal with step-down pravastatin therapy.
Graham MR; Lindsey CC; Kennedy JA
Pharmacotherapy; 2002 Jan; 22(1):21-6. PubMed ID: 11794427
[TBL] [Abstract][Full Text] [Related]
25. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
Ridker PM; Morrow DA; Rose LM; Rifai N; Cannon CP; Braunwald E
J Am Coll Cardiol; 2005 May; 45(10):1644-8. PubMed ID: 15893181
[TBL] [Abstract][Full Text] [Related]
26. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
Jones P; Kafonek S; Laurora I; Hunninghake D
Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
[TBL] [Abstract][Full Text] [Related]
27. Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Baimbridge C; Davis BR; Barzilay J; Basile JN; Henriquez MA; Huml A; Kopyt N; Louis GT; Pressel SL; Rosendorff C; Sastrasinh S; Stanford C;
Am J Kidney Dis; 2008 Sep; 52(3):412-24. PubMed ID: 18676075
[TBL] [Abstract][Full Text] [Related]
28. Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study.
Kietsiriroje N; Leelawattana R
BMC Res Notes; 2015 Jul; 8():294. PubMed ID: 26148680
[TBL] [Abstract][Full Text] [Related]
29. A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE).
Ito H; Ouchi Y; Ohashi Y; Saito Y; Ishikawa T; Nakamura H; Orimo H
J Atheroscler Thromb; 2001; 8(2):33-44. PubMed ID: 11770708
[TBL] [Abstract][Full Text] [Related]
30. Cholesterol lowering. Should it continue to be the last thing we do?
Waters D
Circulation; 1999 Jun; 99(25):3215-7. PubMed ID: 10385491
[No Abstract] [Full Text] [Related]
31. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A;
Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192
[TBL] [Abstract][Full Text] [Related]
32. The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia.
Stein JH; Carlsson CM; Papcke-Benson K; Aeschlimann SE; Bodemer A; Carnes M; McBride PE
J Am Coll Cardiol; 2001 Dec; 38(7):1806-13. PubMed ID: 11738278
[TBL] [Abstract][Full Text] [Related]
33. Statin treatment in hypercholesterolemic pregnant mice reduces cardiovascular risk factors in their offspring.
Elahi MM; Cagampang FR; Anthony FW; Curzen N; Ohri SK; Hanson MA
Hypertension; 2008 Apr; 51(4):939-44. PubMed ID: 18285616
[TBL] [Abstract][Full Text] [Related]
34. Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients.
Tamura A; Watanabe T; Nasu M
Circ J; 2003 Oct; 67(10):816-20. PubMed ID: 14578611
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
Jacotot B; Benghozi R; Pfister P; Holmes D
Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.
Pan HY; DeVault AR; Brescia D; Willard DA
Clin Ther; 1991; 13(3):368-72. PubMed ID: 1954638
[TBL] [Abstract][Full Text] [Related]
37. Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study).
Sasaki J; Otonari T; Sawayama Y; Hata S; Oshima Y; Saikawa T; Biro S; Kono S;
J Atheroscler Thromb; 2012; 19(5):485-93. PubMed ID: 22659533
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of statins on arterial pressure and stiffness of hypertensives.
Ichihara A; Hayashi M; Koura Y; Tada Y; Kaneshiro Y; Saruta T
J Hum Hypertens; 2005 Feb; 19(2):103-9. PubMed ID: 15361892
[TBL] [Abstract][Full Text] [Related]
39. Effect of folic acid combined with pravastatin on arteriosclerosis in elderly hypertensive patients with lacunar infarction.
Li C; Bu X; Liu Y
Medicine (Baltimore); 2021 Jul; 100(28):e26540. PubMed ID: 34260532
[TBL] [Abstract][Full Text] [Related]
40. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
Sasaki S; Nakagawa M; Nakata T; Azuma A; Sawada S; Takeda K; Asayama J;
Circ J; 2002 Jan; 66(1):47-52. PubMed ID: 11999665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]